Trial intelligence / Profile preview

Effects of remimazolam on motor evoked potentials in pediatric spine/spinal cord surgery

jRCTs041230165Not yet recruiting

Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of remimazolam in Back disorder and Spinal Cord Abnormalities. Planned start Mar 2024; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

Back disorderSpinal Cord Abnormalities

Beyond the preview

Go deeper on jRCTs041230165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041230165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call